Noa Krawczyk
Noa Krawczyk, PhD
NYU Langone Health, Division of Epidemiology, Center for Opioid Epidemiology and Policy, Department of Population Health - Assistant Professor
PhD, Mental Health, Johns Hopkins Bloomberg School of Public Health
BA, Biology, Hunter College at the City University of New York – Macaulay Honors College
Research Interests
Substance use, Opioids, Overdose, Health services, Mental health, Criminal justice, Treatment
Noa Krawczyk is an Assistant Professor in the Department of Population Health at NYU School of Medicine and a member of the Center for Opioid Epidemiology and Policy. She completed her PhD in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health, where she studied substance use epidemiology, and previously worked as a Fulbright research scholar to study treatment and health services among cocaine users in Brazil. Her research focuses on studying ways to address barriers to evidence-based treatment for opioid use disorders and improving quality and effectiveness of care, especially among vulnerable groups such as persons with criminal justice involvement. Her work centers on bridging research and practice by collaborating with health organizations, public health and government agencies and advancing science that can help inform evidence-based policies and practices that reduce harm and promote long term recovery.
Principal Investigator, Trends in Psychosis Related to Hospitalizations Among Youth Following Cannabis Legalization in Colorado. Active


Krawczyk N, da Mota JC, Coutinho C, Bertoni N, de Vasconcellos MTL, Silva PLN, De Boni RB, Cerda M, Bastos FI (2021).
Polysubstance use in a Brazilian national sample: Correlates of co-use of alcohol and prescription drugs
Substance Abuse [Epub 2021 Jul 20]. doi: 10.1080/08897077.2021.1949666.

Krawczyk N, Williams AR, Saloner B, Cerda M (2021).
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
Journal of Substance Abuse Treatment, 126, 108329. doi: 10.1016/j.jsat.2021.108329. PMCID: PMC8197774.

Friedman SR, Williams LD, Guarino H, Mateu-Gelabert P, Krawczyk N, Hamilton L, Walters SM, Ezell JM, Khan M, Di Iorio J, Yang LH, Earnshaw VA (2021).
The stigma system: How sociopolitical domination, scapegoating, and stigma shape public health
Journal of Community Psychology [Epub 2021 Jun 11]. doi: 10.1002/jcop.22581.

Krawczyk N, Bunting AM, Frank D, Arshonsky J, Gu Y, Friedman SR, Bragg MA (2021).
“How will I get my next week’s script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic
International Journal of Drug Policy, 92, 103140. doi: 10.1016/j.drugpo.2021.103140.

Han BH, Doran KM, Krawczyk N (2021).
National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness
Journal of Substance Abuse Treatment [Epub 2021 May 29]. doi: 10.1016/j.jsat.2021.108504.


Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D (2019).
Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap
Journal of Substance Abuse Treatment, 103, 1-8. doi: 10.1016/j.jsat.2019.05.002. PMCID: PMC6612429.

Krawczyk N, Picher CE, Feder KA, Saloner B (2017).
Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine
Health Affairs, 36 (12), 2046-2053. doi: 10.1377/hlthaff.2017.0890. PMCID: PMC6035729.

Dr. Krawczyk's MyBibliography Profile
Selected Press